How Howie Mandel turned a panic attack into a mental health movement and helped build a company now worth hundreds of millions

Howie Mandel's mental health advocacy campaign with NOCD, a telehealth platform for OCD treatment, has generated significant celebrity interest and helped establish the company as a major player in digital mental health. The initiative demonstrates how celebrity endorsements can accelerate growth in the healthtech sector, with NOCD now valued at hundreds of millions of dollars.

Howie Mandel's partnership with NOCD represents a compelling case study in how personal advocacy can drive commercial success in digital health. Mandel's willingness to publicly discuss his own panic attacks and mental health struggles lends authentic credibility to NOCD's mission, distinguishing the company in a crowded telehealth market where consumer trust remains paramount. The resulting celebrity momentum—with Billy Bob Thornton and other high-profile figures joining the movement—creates a network effect that amplifies brand visibility far beyond traditional marketing budgets.

The mental health technology sector has experienced explosive growth as digital-first consumers increasingly prefer remote treatment options over traditional in-office care. NOCD's focus on OCD specifically addresses a previously underserved market segment, where specialized expertise and accessible treatment options remain limited. Mandel's involvement transforms the company from a niche healthtech startup into a culturally relevant movement, reducing stigma around both OCD and digital mental health solutions.

For investors, this trajectory signals the broader viability of celebrity-backed healthtech ventures that solve real clinical problems. The ability to attract high-profile partners without substantial paid endorsement costs indicates strong organic product-market fit and consumer demand. NOCD's hundreds-of-millions valuation reflects investor confidence that digital mental health will capture significant market share from traditional psychiatric care.

The challenge ahead involves maintaining clinical credibility while scaling user acquisition through celebrity partnerships. Regulatory scrutiny of telehealth claims and long-term patient outcome tracking will determine whether NOCD can sustain its valuation and market position as competition intensifies.

• →Celebrity advocacy in healthtech can accelerate user acquisition and company valuations without proportional marketing spend
• →NOCD's focus on OCD addresses a underserved patient population within the broader digital mental health market
• →Authentic personal stories from founders and partners build consumer trust more effectively than traditional advertising
• →Digital mental health companies achieving hundreds-of-millions valuations face increasing regulatory and clinical outcome scrutiny
• →The success of celebrity-driven health campaigns depends on sustained clinical credibility and long-term patient satisfaction metrics